Cargando…

Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363

Detalles Bibliográficos
Autor principal: Atkinson, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114391/
http://dx.doi.org/10.2337/db11-0365
_version_ 1782206059985764352
author Atkinson, Mark A.
author_facet Atkinson, Mark A.
author_sort Atkinson, Mark A.
collection PubMed
description
format Online
Article
Text
id pubmed-3114391
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31143912012-06-01 Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 Atkinson, Mark A. Diabetes Online Letters to the Editor American Diabetes Association 2011-06 2011-05-21 /pmc/articles/PMC3114391/ http://dx.doi.org/10.2337/db11-0365 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters to the Editor
Atkinson, Mark A.
Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_full Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_fullStr Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_full_unstemmed Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_short Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_sort response to comment on: atkinson. it's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. diabetes 2011;60:361–363
topic Online Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114391/
http://dx.doi.org/10.2337/db11-0365
work_keys_str_mv AT atkinsonmarka responsetocommentonatkinsonitstimetoconsiderchangingtherulestherationaleforrethinkingcontrolgroupsinclinicaltrialsaimedatreversingtype1diabetesdiabetes201160361363